EVALUATE LIMITED — United States · Federal contract register · Supplier record: 9 contracts, all years ($388,069 · May 2010 – Sep 2025); $47.1K since January 2024 (2 contracts · 1 agency); — rank in the line (of 110 suppliers · 0.0%); 10 agencies never served ($208M on the line without EVALUATE LIMITED).
Assay record ASY-US-1OAI0D21T5 · Cite as: Assay Systems, “EVALUATE LIMITED in the USAspending register”, https://assay-systems.com/register/us/evaluate-limited/
9
contracts, all years
$388,069 · May 2010 – Sep 2025
$47.1K
since January 2024
2 contracts · 1 agency
—
rank in the line
of 110 suppliers · 0.0%
10
agencies never served
$208M on the line without EVALUATE LIMITED
Own record by year
2020 onward
$115K
$23.0K
$24.1K
2020202120222023202420252026
Who buys from EVALUATE LIMITED
since January 2024
1agencies
$47.1Kpaid
100.0%top buyer
Federal Trade Commission100.0%
$47,150
The line
since January 2024
$208Mline value
258contracts
10agencies
110suppliers
70.3%held by top ten
Specialized medical support (Q701)
$123M
$64.7M
$20.2M
202420252026Jan–Sep
—of 110 suppliers
$0EVALUATE LIMITED in the line
0.0%share of the line
Agencies that buy the line and never bought from EVALUATE LIMITED
10agencies
258contracts
$207,692,008since January 2024
Department of Health and Human Services54 contracts
Source: USAspending.gov, U.S. Department of the Treasury, Bureau of the Fiscal Service, usaspending.gov, accessed 30 September 2026.The data is available to copy, adapt, redistribute, or otherwise use for non-commercial or for commercial purposes (USAspending.gov, Licensing); no Dun & Bradstreet data is shown.